Ontario Industry Updates

Springboard’s Health Innovation Hub: 2018 Applications Now Open

Springboard’s Health Innovation Hub is a program for women-led life science and digital health companies seeking seed and growth funding and expert connections. The program runs in two tracks: Life Science and Digital Health.

Selected companies will be matched with a team of relevant, targeted advisors and participate in several in-person and virtual workshops and presentation sessions throughout the year that provide exposure to influencers, active investors, and potential strategic partners.

New Funding Available: HealthBound II - Improve Patient Wait Times in an Outpatient Clinic at St. Michael's

The Biomedical Zone has opened up applications for HealthBound II, aimed at finding a solution to improve patient wait times in an outpatient clinic at St. Michael's.

  • The winning company will receive:
  • A cash prize of $5000
  • Residency in the Biomedical Zone
  • A subsidized pilot opportunity at St. Michael's 
  • Mentorship and immersion from clinicians, hospital administrators, and IT

Thornhill Research & Rostrum Medical Announce Technology Development Agreement

TORONTO, ON  Thornhill and Rostrum celebrate the finalization of a Technology Development Agreement which includes the licensing of certain Thornhill IP and an investment by Rostrum into Thornhill. This agreement is aimed to further Rostrum’s development of its Pulmonary Health Monitoring during ventilation, in ICU, OR and ER applications while supporting Thornhill’s commercialization efforts of their own innovative products.

KalGene Pharmaceuticals Closes Financing to Support the Clinical Development of its Alzheimer's Therapeutic

TORONTO, ON  KalGene Pharmaceuticals announced the closing of a Series A financing to support the advancement of its lead Alzheimer's therapeutic program. The syndicated investment was led by Lumira Capital and included participation from Anges Québec, Anges Québec Capital, Accel-Rx Health Sciences Accelerator and a number of Canadian family offices. In addition to the equity financing the company has also received significant financial support from leading Foundations focused on neurodegenerative diseases. Proceeds from these combined funding sources will support the development of KalGene's lead Alzheimer's therapeutic candidate.

CCAB Welcomes Mr. Robert Verhagen as New CEO

The Centre for the Commercialization of Antibodies and Biologics (CCAB) Board of Directors is pleased to announce the appointment of Mr. Robert Verhagen as the organization’s new Chief Executive Officer, effective November 1, 2017.

As CCAB’s new CEO, Mr. Verhagen will provide his strategic direction to position CCAB as a leader in the commercialization of academic discoveries in the biologics field and in the advancement of this biotech sector in Canada.

Canadian Technology Accelerator (CTA) Initiative Accepting Applications - Spring 2018 Cohorts (February–June 2018)

Application Deadline January 10, 2018 - Apply Here

The Canadian Technology Accelerator Initiative (CTA) helps high-potential, high-growth Canadian technology SMEs seeking to expand to the U.S through a 5 month program of workshops, events, mentorship and business introductions.

Baylis Devices & Expanded Training Program: European Doctors Learn to Access the Heart from Any Approach

Baylis Medical Company Inc. has launched a hands-on workshop in Europe that will train cardiologists on innovative tools that enable access to the heart from any approach. This includes a growing number of procedures that require physicians to use major veins that feed into the heart from above.

Funding Opportunity: MaRS Procurement by Co-Design Program

Deadline for Submission October 13, 2017, 5PM EST

Innovation Partnership: Procurement by Co-Design is a unique program that offers healthcare-service providers something rare: the opportunity to participate in the development of innovative solutions before procuring them. In turn, technology and service innovators with scalable business models can gain unprecedented access to end users and validate use cases to remain competitive.

Analysis: Update to Ontario's Health Sector Payment Transparency Act, By Norton Rose Fulbright

The Ontario Minister of Health and Long-Term Care (the “Minister”) introduced Bill 160:
An Act to amend, repeal and enact various Acts in the interest of strengthening quality and
accountability for patients on September 27, 2017. One of the new enactments is the Health Sector Payment Transparency Act (the “Act”) which will require the reporting of information about financial relationships in the Ontario healthcare system.

Synaptive Medical Appoints Peter Wehrly as Ceo

TORONTO, ON (October 5, 2017) – Synaptive Medical, a leading Canadian medical device and technology company, announced today the appointment of veteran healthcare executive and current chairman of the board Peter Wehrly as chief executive officer. Cameron Piron will continue to serve as president and assume the new role of chief strategy officer.